The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--no

Mult Scler. 2012 May;18(5):557-8. doi: 10.1177/1352458512443995.

Authors

M Filippi¹, M A Rocca

Affiliation

¹ Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy. m.filippi@hsr.it

PMID: 22547411
DOI: 10.1177/1352458512443995

No abstract available

MeSH terms

Atrophy
Brain / pathology*
Brain / physiopathology
Disability Evaluation
Humans
Magnetic Resonance Imaging*
Multiple Sclerosis / diagnosis*
Multiple Sclerosis / pathology
Multiple Sclerosis / physiopathology
Predictive Value of Tests
Prognosis
Reproducibility of Results
Severity of Illness Index